Identification of tp53 gene mutations in sporadic, familial breast cancer cases and Li.Fraumeni syndrome. Is codon 72 polymorphism of tp53 gene can be consider as an important mutation marker

被引：0
|
作者：
Aziz, I. [1 ]
Ali, S. [1 ]
Shakoori, A. R. [1 ]
机构：
[1] Univ Punjab, Sch Biol Sci, Lahore, Pakistan
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71569-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [21] A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene
    Baccouche, S
    Mabrouk, I
    Said, S
    Mosbah, A
    Jlidi, R
    Gargouri, A
    CANCER LETTERS, 2003, 189 (01) : 91 - 96
  • [22] TP53 Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy
    Vieira, Jussane Oliveira
    Pesquero, Joao Bosco
    Nazario, Afonso Celso Pinto
    BREAST CARE, 2024, 19 (02) : 96 - 105
  • [23] TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population
    Amir Hossain
    Gazi Md. Monjur Murshid
    Md. Nazmul Hasan Zilani
    Fahrima Islam
    Razia Sultana
    Tamanna Sultana
    Md. Golam Hossain
    Md. Mustafizur Rahman
    Breast Cancer, 2017, 24 : 571 - 578
  • [24] Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk
    Damin, Andrea P. S.
    Frazzon, Ana P. G.
    Damin, Daniel C.
    Roehe, Adriana
    Hermes, Vanessa
    Zettler, Claudio
    Alexandre, Claudio O. P.
    CANCER DETECTION AND PREVENTION, 2006, 30 (06): : 523 - 529
  • [25] TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population
    Hossain, Amir
    Murshid, Gazi Md. Monjur
    Zilani, Md. Nazmul Hasan
    Islam, Fahrima
    Sultana, Razia
    Sultana, Tamanna
    Hossain, Md. Golam
    Rahman, Md. Mustafizur
    BREAST CANCER, 2017, 24 (04) : 571 - 578
  • [26] The Li-Fraumeni syndrome revisited from 415 carriers of the mutation of the TP53 gene
    Bougeard, G.
    Renaux-Petel, M.
    Flaman, J. -M.
    Charbonnier, C.
    Fermey, P.
    Belotti, M.
    Gauthier-Villars, M.
    Stoppa-Lyonnet, D.
    Consolino, E.
    Brugieres, L.
    Caron, O.
    Benusiglio, P. -R.
    Bressac-de Paillerets, B.
    Bonadona, V.
    Bonaiti-Pellie, C.
    Tinat, J.
    Baert-Desurmont, S.
    Frebourg, T.
    BULLETIN DU CANCER, 2015, 102 (06) : S125 - S125
  • [27] A Novel Variant in the TP53 Gene Causing Li-Fraumeni Syndrome
    Papadimitriou, Dimitrios T.
    Stratakis, Constantine A.
    Kattamis, Antonis
    Glentis, Stavros
    Dimitrakakis, Constantine
    Spyridis, George P.
    Christopoulos, Panagiotis
    Mastorakos, George
    Vlahos, Nikolaos F.
    Iacovidou, Nicoletta
    CHILDREN-BASEL, 2023, 10 (07):
  • [28] A novel germline mutation of TP53 with breast cancer diagnosed as Li-Fraumeni syndrome
    Kai, Masaya
    Kubo, Makoto
    Shikada, Sawako
    Hayashi, Saori
    Morisaki, Takafumi
    Yamada, Mai
    Takao, Yuka
    Shimazaki, Akiko
    Harada, Yurina
    Kaneshiro, Kazuhisa
    Mizuuchi, Yusuke
    Shindo, Koji
    Nakamura, Masafumi
    SURGICAL CASE REPORTS, 2022, 8 (01)
  • [29] Prognostic value genotypes and LOH at TP53 codon 72 and TP53mutations in primary breast cancer
    M Kyndi
    J Alsner
    LL Hansen
    FB Sørensen
    J Overgaard
    Breast Cancer Research, 7
  • [30] Codon 72 Polymorphism Of TP53 Gene Is a Novel Prognostic Marker For Thalidomide Therapy In Multiple Myeloma
    Hattori, Yutaka
    Ikeda, Yurika
    Suzuki, Yuya
    Ichikawa, Daiju
    Matsushita, Maiko
    BLOOD, 2013, 122 (21)
12345